2 shares with explosive long-term growth potential

These stocks have the potential to produce growth for years to come.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Shares in Vectura (LSE: VEC) are shooting higher today after the company reported an impressive set of results for the nine-months ending 31 December. The results, which show the first six month period after the firm’s merger with peer Skyepharma back in June, revealed revenue in the nine-month period was up 76% to £126.5m from the £72m generated in the prior 12-month period. Recurring revenue accounted for 80% versus 60%. 

Earnings before interest, tax, depreciation and amortisation in the nine-month period hit £34.1m, up from the £23.2m reported for the prior 12-month period.

Cash is king

On a pro-forma basis that compares the nine months to the end of 2016 versus the nine months to the end of 2015, revenue was up 27% to £115.6m from £91.6m while EBITDA was up 57% to £17m from £10.8m.

Unfortunately, due to higher amortisation charges of £64m, compared to just £18.8m for the prior 12-month period, Vectura’s pre-tax loss ballooned to £40.1m. But in many ways this accounting loss is irrelevant. What really matters is its cash generation. During the nine-month period, the company generated £28.2m of cash, taking the cash balance to £92.5m at the end of the period, almost 9% of Vectura’s market capitalisation. 

As it shortened its financial year after merging with Skyepharma, these results should be interpreted as the group’s full-year 2016 results. Analysts had been expecting a loss from the company but going forward they believe its earnings will surge. For 2017 earnings per share growth of 27% is pencilled-in and for 2018 growth of 48% is expected as the firm continues to roll out new products. 

Even though shares in Vectura currently trade a forward P/E of 25.4, this growth is certainly worth paying for, especially considering its cash balance. The company does not currently offer a dividend although considering the cash pile it holds, I wouldn’t rule out a dividend in the near future. 

Dividend champion 

As well as Vectura, shares in National Accident Helpline (LSE: NAHL) are also rising today following an upbeat set of results from the company. 

For the year ending 31 December, underlying revenue declined 2.6% to £49.4m but underlying operating profit rose 15.1% to £18m thanks to an improvement in the firm’s operating profit margin from 30.8% to 36.4%. Profit before tax increased 13.3% to £15.8m and basic earnings per share rose 1.4p to 27p. Off the back of these results, management has increased NAHL’s dividend payout for the year by 1.6% to 19.1p giving a dividend yield of 11.4%. 

City analysts are not optimistic about NAHL’s outlook but today’s results should alleviate concerns about the company’s future. Falling revenue but rising profitability shows that NAHL can adapt to the changing regulatory environment, which is good news for shareholders. 

And even if earnings collapse as predicted over the next two years (analysts have pencilled-in a 30% decline in earnings per share) the shares still look cheap. Based on 2018 forecasts, shares in NAHL currently trade at a forward P/E of 8.2 and support a dividend yield of 8.6%. 

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Rupert Hargreaves owns shares in Vectura. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Nvidia shares could reach $1,000 in 2024

Up 100 times since 2016 and yet Nvidia shares still might be cheap! Read on to find out whether our…

Read more »

Investing Articles

Should I take advantage of the rising easyJet share price to buy it in an ISA today?

The easyJet share price has jetted back into the FTS 100 as it recovers from the pandemic and Harvey Jones…

Read more »

Three signposts pointing in different directions, with 'Buy' 'Sell' and 'Hold' on
Investing Articles

2 FTSE 100 stocks to buy for a ‘technical recession’

Not all stocks are well suited to a recessionary environment, but here are two FTSE 100 titans that our writer…

Read more »

Young black colleagues high-fiving each other at work
Investing Articles

Here’s why the Haleon share price jumped 6% higher today

As the Haleon share price rises, our writer considers whether he should add this consumer healthcare stock to his portfolio.

Read more »

Smart young brown businesswoman working from home on a laptop
Investing Articles

Last-minute ISA buys! 2 dirt-cheap dividend stocks I’d grab before April’s deadline

Aviva and Greencoat UK Wind shares look stunningly cheap at current prices. Here Royston Wild explains why he's looking to…

Read more »

Young happy white woman loading groceries into the back of her car
Investing Articles

Should I buy, as the Ocado share price perks up on FY results?

The Ocado share price is steady, as the online retail giant reports a big fall in 2023 losses. Is it…

Read more »

Illustration of flames over a black background
Investing Articles

Here’s another top buy from the FTSE 250 I’m considering

Oliver Rodzianko considers this FTSE 250 company a stellar choice for his portfolio. It's on his growth watchlist; so let's…

Read more »

A young Asian woman holding up her index finger
Investing Articles

A “once in a lifetime” opportunity for Rolls-Royce shares?

One firm is hoping now is a “once in a lifetime” opportunity for UK nuclear companies. Our writer reveals whether…

Read more »